Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?

Luk CP, Parsons R, Lee YP, Hughes JD.

Ann Pharmacother. 2013 Jun;47(6):773-80. doi: 10.1345/aph.1R556. Epub 2013 Apr 30. Review.

PMID:
23632281
2.

The association of proton pump inhibitors and hypomagnesemia in the community setting.

Markovits N, Loebstein R, Halkin H, Bialik M, Landes-Westerman J, Lomnicky J, Kurnik D.

J Clin Pharmacol. 2014 Aug;54(8):889-95. doi: 10.1002/jcph.316. Epub 2014 May 6.

PMID:
24771616
3.

A case series of proton pump inhibitor-induced hypomagnesemia.

Hoorn EJ, van der Hoek J, de Man RA, Kuipers EJ, Bolwerk C, Zietse R.

Am J Kidney Dis. 2010 Jul;56(1):112-6. doi: 10.1053/j.ajkd.2009.11.019. Epub 2010 Feb 26.

PMID:
20189276
4.

Response to "Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?".

Luk CP, Parsons R, Lee YP, Hughes JD.

Ann Pharmacother. 2014 Mar;48(3):432. doi: 10.1177/1060028013512832. No abstract available.

PMID:
24586075
5.

Comments on "Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?".

Famularo G.

Ann Pharmacother. 2014 Mar;48(3):431. doi: 10.1177/1060028013512831. No abstract available.

PMID:
24586074
6.

Uses of proton pump inhibitors and hypomagnesemia.

Gau JT, Yang YX, Chen R, Kao TC.

Pharmacoepidemiol Drug Saf. 2012 May;21(5):553-9. doi: 10.1002/pds.3224. Epub 2012 Feb 15.

PMID:
22337212
7.

Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.

Nakashima A, Ohkido I, Yokoyama K, Mafune A, Urashima M, Yokoo T.

PLoS One. 2015 Nov 30;10(11):e0143656. doi: 10.1371/journal.pone.0143656. eCollection 2015.

PMID:
26618538
8.

Hypomagnesemia associated with a proton pump inhibitor.

Matsuyama J, Tsuji K, Doyama H, Kim F, Takeda Y, Kito Y, Ito R, Nakanishi H, Hayashi T, Waseda Y, Tsuji S, Takemura K, Yamada S, Okada T, Kanaya H.

Intern Med. 2012;51(16):2231-4. Epub 2012 Aug 15.

PMID:
22892510
9.

Hypomagnesemia and proton-pump inhibitors.

Famularo G, Gasbarrone L, Minisola G.

Expert Opin Drug Saf. 2013 Sep;12(5):709-16. doi: 10.1517/14740338.2013.809062. Epub 2013 Jun 29. Review.

PMID:
23808631
10.

Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.

Sharara AI, Chalhoub JM, Hammoud N, Harb AH, Sarkis FS, Hamadeh G.

Clin Gastroenterol Hepatol. 2016 Feb;14(2):317-21. doi: 10.1016/j.cgh.2015.10.012. Epub 2015 Oct 20.

PMID:
26499924
11.

Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.

Kieboom BC, Kiefte-de Jong JC, Eijgelsheim M, Franco OH, Kuipers EJ, Hofman A, Zietse R, Stricker BH, Hoorn EJ.

Am J Kidney Dis. 2015 Nov;66(5):775-82. doi: 10.1053/j.ajkd.2015.05.012. Epub 2015 Jun 26.

PMID:
26123862
12.

Serum magnesium and proton-pump inhibitors use: a cross-sectional study.

Faulhaber GA, Ascoli BM, Lubini A, Mossmann M, Rossi G, Geib G, Furlanetto TW.

Rev Assoc Med Bras (1992). 2013 May-Jun;59(3):276-9. doi: 10.1016/j.ramb.2012.12.007. Epub 2013 May 13.

PMID:
23680271
13.

Perils and pitfalls of long-term effects of proton pump inhibitors.

Wilhelm SM, Rjater RG, Kale-Pradhan PB.

Expert Rev Clin Pharmacol. 2013 Jul;6(4):443-51. doi: 10.1586/17512433.2013.811206. Review.

PMID:
23927671
14.

Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.

Furlanetto TW, Faulhaber GA.

Arch Intern Med. 2011 Aug 8;171(15):1391-2. doi: 10.1001/archinternmed.2011.199. Epub 2011 May 9.

PMID:
21555654
15.

Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies.

Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, Srivali N, Edmonds PJ, Ungprasert P, O'Corragain OA, Korpaisarn S, Erickson SB.

Ren Fail. 2015 Aug;37(7):1237-41. doi: 10.3109/0886022X.2015.1057800. Epub 2015 Jun 25. Review.

PMID:
26108134
16.

The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.

Park CH, Kim EH, Roh YH, Kim HY, Lee SK.

PLoS One. 2014 Nov 13;9(11):e112558. doi: 10.1371/journal.pone.0112558. eCollection 2014. Review.

PMID:
25394217
17.

An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.

dos Santos LM, Guerra RA, Lazaretti-Castro M, Vieira JG, Portes Ede S, Dias-da-Silva MR.

Magnes Res. 2015 Dec;28(4):136-45. doi: 10.1684/mrh.2015.0395.

PMID:
26878253
18.

Proton-pump inhibitor use is associated with low serum magnesium concentrations.

Danziger J, William JH, Scott DJ, Lee J, Lehman LW, Mark RG, Howell MD, Celi LA, Mukamal KJ.

Kidney Int. 2013 Apr;83(4):692-9. doi: 10.1038/ki.2012.452. Epub 2013 Jan 16.

PMID:
23325090
19.

Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.

Koulouridis I, Alfayez M, Tighiouart H, Madias NE, Kent DM, Paulus JK, Jaber BL.

Am J Kidney Dis. 2013 Oct;62(4):730-7. doi: 10.1053/j.ajkd.2013.02.373. Epub 2013 May 10.

PMID:
23664547
20.

Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia.

Kim S, Lee H, Park CH, Shim CN, Lee HJ, Park JC, Shin SK, Lee SK, Lee YC, Kim HY, Kang DR.

Am J Ther. 2015 Jan-Feb;22(1):14-21. doi: 10.1097/MJT.0b013e31829c4c71.

PMID:
23846522

Supplemental Content

Support Center